TITLE

Endocare Sells $5M Convert Deal

AUTHOR(S)
Matta, L. Matthew
PUB. DATE
June 1999
SOURCE
Private Placement Letter;06/21/99, Vol. 17 Issue 25, p4
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Focuses on the convertible debentures placed by Endocare Inc. with the investment funds managed by Brown Simpson Asset Management LLC. Purpose of the financing; Conversion price of the debentures; Terms of the deal.
ACCESSION #
1978153

 

Related Articles

  • CryoFluor Raises Trial Money From Endocare, Temple. Reed, Vita // Orange County Business Journal;1/17/2005, Vol. 28 Issue 3, p8 

    Reports on the investments of Endocare Inc. and the Temple University in CryoFluor Therapeutics LLC. Use of the money in the development of a device designed to treat abnormal uterine bleeding; Significance of the investment for the business activity of CryoFluor Therapeutics; Company operations.

  • Endocare, Inc. Flaherty, Robert J.; Schoeman, Roger // Equities Special Situations;4/30/96-5/31/96, Issue 442, p1 

    Profiles Endocare Inc. and its stock market potential. History; Price quoted for the recommended stock; Product development; Management; Financial data; Finances; Risks; Contact information.

  • Special Situations Recommendations Still Open on 1/1/00 and Subsequent Recommendations.  // Equities Special Situations;Jun2002, Issue 502, p8 

    Lists companies recommended for equity investing. Opinion Research Corp.; ATS Money Systems; Endocare.

  • CRYOSURGERY. Blacklidge, Julie // Fort Worth Business Press;8/16/2002, Vol. 15 Issue 33, p21 

    Discusses how cryosurgery was improved by the Endocare Inc., the leading provider of advanced patented technologies. Use of cryoablation to treat prostate cancer by freezing the cancer cells with metal probes containing argon gas; Safety associated with the use of the technique.

  • Endocare Plans New Offering as Shares Rise. Reed, Vita // Orange County Business Journal;11/12/2001, Vol. 24 Issue 46, p3 

    Reports the sale of shares on common stock by Endocare Inc. in Irvine, California. Proceeds of the sale; Increase in the share price of the company due to the offering announcement; Lead underwriters on the stock offering of Endocare.

  • Endocare Grows as Cancer Treatments, Acquisitions Raise Three-Year Revenue. Reed, Vita // Orange County Business Journal;10/28/2002, Vol. 25 Issue 43, p27 

    Features Irvine, California-based Endocare Inc. Sales growth for the three years ended June 30, 2002; Features of the company's main product, Cryocare; Merger and acquisition deals.

  • Proud to support all referring practices.  // British Dental Journal;3/23/2013, Vol. 214 Issue 6, p314 

    The article reports that EndoCare Inc. takes pride in offering exceptional service and support to all referring practices pertaining to the diagnosis and treatment of dental pain and infection across London, England.

  • $12.1 million refunding deal should keep Maryland investors satisfied. Albano, Christine // Bond Buyer;10/20/97, Vol. 322 Issue 30255, p9 

    No abstract available.

  • Seeking Shelter From the Storm in Munis. Legomsky, Joanne // Bond Buyer;11/27/2000, Vol. 334 Issue 31024, Mutual Funds p18 

    Focuses on investment in Treasury bonds in the United States. Fallibility of the U.S. equity markets; Earnings of corporate bonds; Bonds versus funds.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics